Saturday, October 2, 2021

Highlighting the Significant Strides Made in Friedreich Ataxia Care

NeurologyLive. October 1, 2021. David R. Lynch, MD, PhD, professor of neurology, University of Pennsylvania Perelman School of Medicine, discussed why omaveloxolone’s recent success speaks to the progress made within the FA treatment space.